Clinical Trials Browser

Phase 2/3 × Decitabine × Other hematologic neoplasm × Clear all

NCT03092674 2025-01-16

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Phase 2/3 Completed

76 enrolled 16 charts

MyeloidOther hematologic neoplasm

GATA2 Deficiency, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03530085 2020-12-22

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03793517 2020-03-10

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02272478 2020-01-23

AML18

Phase 2/3 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02472145 2019-03-19

An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

Phase 2/3 Completed

326 enrolled 20 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03256071 2017-08-21

Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00398983 2013-03-04

Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)

Phase 2/3 Completed

50 enrolled 6 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute